Search

Search Constraints

You searched for: Author/Creator Rausch, C.

Search Results

1. Guselkumab is superior to fumaric acid esters in patients with moderate‐to‐severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active‐comparator‐controlled phase IIIb trial (POLARIS). (20th January 2020)

2. Guselkumab is superior to fumaric acid esters in patients with moderate‐to‐severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active‐comparator‐controlled phase IIIb trial (POLARIS). (1st August 2020)

3. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. (December 2019)